Janux Therapeutics (JANX) Research & Development: 2020-2025
Historic Research & Development for Janux Therapeutics (JANX) over the last 6 years, with Sep 2025 value amounting to $34.6 million.
- Janux Therapeutics' Research & Development rose 86.04% to $34.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $115.2 million, marking a year-over-year increase of 92.49%. This contributed to the annual value of $68.4 million for FY2024, which is 24.52% up from last year.
- Latest data reveals that Janux Therapeutics reported Research & Development of $34.6 million as of Q3 2025, which was down 0.10% from $34.7 million recorded in Q2 2025.
- Janux Therapeutics' 5-year Research & Development high stood at $34.7 million for Q2 2025, and its period low was $1.9 million during Q1 2021.
- Its 3-year average for Research & Development is $19.8 million, with a median of $15.9 million in 2023.
- As far as peak fluctuations go, Janux Therapeutics' Research & Development soared by 1,033.91% in 2021, and later decreased by 20.69% in 2023.
- Quarterly analysis of 5 years shows Janux Therapeutics' Research & Development stood at $11.2 million in 2021, then skyrocketed by 38.19% to $15.4 million in 2022, then declined by 20.69% to $12.2 million in 2023, then spiked by 69.97% to $20.8 million in 2024, then spiked by 86.04% to $34.6 million in 2025.
- Its Research & Development stands at $34.6 million for Q3 2025, versus $34.7 million for Q2 2025 and $25.1 million for Q1 2025.